Skip to main content
EU Science Hub
Training and workshops

Translating radiotheranostic cancer research into clinical practice in Europe

The JRC is organizing an Experts & Stakeholders Workshop, which will take place at the  European Commission's Joint Research Centre site in Ispra, Italy, on 27th April 2023.

In the follow up of the recent High Level Nuclear Round Table with Commissioner Mariya Gabriel on 13 February 2023, obstacles for a translation of research into a broader use of theranostic radiopharmaceuticals in clinical practice, as well as further expected developments in radiotheranostics will be discussed and identified.

  • cancer | medical research
  • -
  • Ispra, Italy


  1. 27 Apr 2023,
    08:30 AM - 09:15 AM CEST
    Registration & coffee
  2. 09:15 AM - 09:50 AM CEST
    Welcome and Introduction

    EU Commissioner Mariya Gabriel
    JRC DDG Bernard Magenhann
    Representative of Swedish Presidency (t.b.c.)
    Group photo

  3. 09:50 AM - 12:20 PM CEST
    Session 1 – Radiotheranostics: radionuclide-based therapy and companion diagnostics

    9:50-10:20 - Principles of and clinical experiences with peptide receptor radio-therapy of neuroendocrine tumours and radio-ligand therapy of advanced prostate cancer (Richard P. Baum)
    10:20-10:50 - Results of 177Lu-PSMA-617 phase II prospective trial IRST-185 and role of androgen receptor amplification in PSMA-RLT (Giovanni Paganelli)
    10:50-11:05 - mCRPC patients receiving 225Ac-PSMA-617 therapy in the post–androgen deprivation therapy setting (Alfred Morgenstern)
    11:05-11:20 - Coffee
    11:20-11:50 - The role of Centers of Excellence and multidisciplinary tumor boards for quality treatment of NET (Marianne Pavel)
    11:50-12:20 - Radioligand therapy of metastatic prostate cancer– the oncologists view (Silke Gillessen)

  4. 12:20 PM - 01:00 PM CEST
    Session 2 – The cancer patients’ view

    Erik Briers (Europa Uomo), Anna Nilsson (care giver), Luciano Licciardello and Barbara Picutti (Associazione Pazienti con Tumori Neuroendocrini)

  5. 01:00 PM - 03:00 PM CEST
    Session 3 – Radiotheranostics: innovations and challenges

    13:00-13:30 - Exploiting radiobiological effects of targeted radionuclide therapy (Jean-Pierre Pouget)
    13:30-14:30 - Buffet Lunch
    14:30-15:00 - New developments and challenges facing clinical translation of radiotheranostics (KenHerrmann)

  6. 03:00 PM - 05:00 PM CEST
    Session 4 – Translating radiotheranostics into clinical practice

    All & in addition Odile Jaume (ICPO), Heinz-Peter Schlemmer (EACS), Stefano Fanti (University of Bologna), Konrade von Bremen (Nuclear Medicine Europe), Ulla Engelmann (JRC)
    15:00-15:50 - Identification of critical factors, potential roadblocks and the relevant stakeholders
    15:50-16:00 - Coffee
    16:00-17:00 - How to tackle roadblocks

  7. 05:00 PM - 05:30 PM CEST
    Wrap-up & recommendations
  8. 05:45 PM - 06:00 PM CEST
    Transport to the hotel or airport

Practical information

Joint Research Centre
Ispra, Italy